BOCA RATON, Fla., March 10, 2017 -- A new generation of vision concerns is on the rise as digital device usage continues to grow across all age groups in the U.S. Electronic devices use “blue light” to produce high-energy bright whites on the screen which have been found to damage the retina.
Everyone is at risk. The average American adult spends 11 hours a day in front of an electronic screen, cell phone, tablet, computer and TV, while children are exposed 6.5 hours, and even toddlers receive an average of 2.5 hours of damaging blue light every day.
A major side-effect of blue light exposure is Computer Vision Syndrome, which has replaced carpal tunnel as the #1 workplace complaint. In addition, blue light exposure has been correlated with earlier onset of macular degeneration—down from age 65 to 60 years.
“We’re staring at the perfect storm of vision problems, and we need to take preventive measures before it’s too late,” says Naomi Whittel, CEO and president of Twinlab Consolidation Corporation (TLCC), who, as a mother of four children, is particularly sensitive to this burgeoning health crisis. “Only 2 hours of using a digital device can lead to eye strain, fatigue and dry eyes. Do the math and you can see the impact of all the hours we spend with non-stop screen exposure.” Since taking the reins as CEO a year ago, Whittel has focused on rebuilding the foundation of the Twinlab brand and creating a vision for the future inspired by the best of the brand’s past. Relaunching the eye health category with four new products under the flagship Ocuguard® banner is an example of Twinlab’s commitment to tackling the big health issues of the future today.
Twinlab introduces three cutting-edge products to target eye health nutrition for the digital age:
- Ocuguard® Blutein™ Protection is a revolutionary formula that acts as a nutritional filter against high-energy blue light emitted by cell phones and computer monitors. It features clinically tested Lutemax® 2020 to support healthy eye function in only 12 weeks. For added protection, it includes blueberry extract and fucoxanthin, two powerful antioxidants that help fight oxidative stress associated with blue light.
- Ocuguard® Blutein™ Performance supports faster mental processing and reaction. Computer work and gaming demand sharp visual and mental focus. Designed specifically to boost performance, this cutting-edge formula helps heighten reaction time and energy while protecting against digital eye strain—featuring a proprietary formula so powerful that results start in just 7 days.
- Ocuguard® Blutein™ Chew provides extra protection for young and maturing eyes. Young, developing retinas are especially vulnerable to strain as they absorb more blue light than mature eyes. These tasty fruit chews offer a nutritional shield against the harmful effects of blue light and help minimize eye fatigue. Results start in just 12 weeks.
As part of this launch, the Ocuguard products have been updated—now in vegetable caps, magnesium stearate-free, and with a new packaging look.
Ocuguard® Plus brings comprehensive support for optimal eye health as a total solution that protects against oxidative stress caused by aging, digital devices and the environment. The award-winning Ocuguard® Plus line, now with Lutemax 2020®, delivers an all-in-one formula with antioxidants, vitamins and minerals for eye health and absorption.
"There is now overwhelming data from our lab and others' to support the idea that the nutrients found in the Ocuguard line of products have significant benefits for health and performance,” said James Stringham, Ph.D., Research Professor at the University of Georgia, who has extensively studied the benefits of the nutrient lutein. “These wide-ranging effects include protection against blue light, improved visual and cognitive performance, reduced risk of developing age-related ocular and brain disease, and even reduction of psychological stress." The Ocuguard line of products will be available in health food stores nationwide starting in June.
About Twinlab Consolidated Holdings, Inc.
Twinlab Consolidated Holdings, Inc. ("TLCC") is the parent holding company of Twinlab Consolidation Corporation, an industry-focused health and wellness company committed to developing top brands. TLCC has a portfolio of products that are made in America using the finest ingredients from around the world. In addition to its namesake brand, Twinlab®, established in 1968, TLCC, through TCC and its subsidiaries, also manufactures and sells other well-known category leaders including the Metabolife® line of diet and energy products; the Twinlab® Fuel line of sports nutrition products; Alvita® teas, established in 1922 as a single-herb tea line; Trigosamine® joint support products; and premium nutritional and anti-aging / wellness supplements under the award winning Reserveage™ Nutrition family of brands. TCC also owns NutraScience Labs, a contract manufacturer. Twinlab's manufacturing facility located in American Fork, Utah is an NSF GMP and NSF GMP for Sport certified facility. Visit www.tchhome.com for more information.
Media contact: Dean Draznin 641-472-2257 [email protected] Terri Slater 561-487-7037 [email protected]


Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 



